Niacin as potential treatment for dyslipidemia and hyperphosphatemia associated with chronic renal failure: the need for clinical trials

Niacin improves renal lipid metabolism and slows progression in chronic kidney disease

(2009) Kyu-hyang Cho et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Niacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia

(2009) Helen Vosper   BRITISH JOURNAL OF PHARMACOLOGY

Extended-Release Niacin or Ezetimibe and Carotid Intima–Media Thickness

(2009) Allen J. Taylor et al.   NEW ENGLAND JOURNAL OF MEDICINE

Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells

(2008) Shobha H. Ganji et al.   ATHEROSCLEROSIS

A Randomized, Double-Blind, Placebo-Controlled Trial of Niacinamide for Reduction of Phosphorus in Hemodialysis Patients

(2008) S. C. Cheng et al.   Clinical Journal of the American Society of Nephrology

Hyperphosphatemia and nicotinic acid in peritoneal dialysis patients

(2008) Carlos Guido Musso et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY